Tyrosine Kinase Inhibitor Discontinuation Safe in Pediatric Chronic Myeloid Leukemia
TKI therapy can be safely discontinued in pediatric patients with chronic-phase CML in sustained deep molecular response.
Source: cancertherapyadvisor.com
Lymphoma Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lymphoma Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lymphoma Study Today - Breaking & Trending Today
Tyrosine Kinase Inhibitor Discontinuation Safe in Pediatric Chronic Myeloid Leukemia
Study findings suggest TKI therapy can be safely discontinued in pediatric patients with chronic-phase CML in sustained deep molecular response.
Source: oncologynurseadvisor.com
NuCana plc: NuCana Announces Update for Phase 3 Biliary Tract Cancer Study
Independent Data Monitoring Committee Recommended Study be Discontinued Following Futility Assessment Conducted at First Interim Analysis NUC-3373 Continues Rapid Development with Multiple Data Readouts
Source: finanznachrichten.de
Investegate |NuCana plc Announcements | NuCana plc: NuCana Announces Update for Phase 3 Biliary Tract Cancer Study
Investegate announcements from NuCana plc, NuCana Announces Update for Phase 3 Biliary Tract Cancer Study
Source: investegate.co.uk